National Institutes of Health renews Genomatix License
Expanding contract to include Microarray analysis Package ChipInspector
Genomatix Software GmbH (Munich) announced today that it renewed its license agreement with the NCI under which NIH intramural researchers nation wide do have full access to the Genomatix suite of software tools and databases. The new license includes Genomatix“ ChipInspector which will be released later this year. ChipInspector, as well as all the other Genomatix products, recently have been awarded with the "Gene Chip Compatible" status from Affymetrix Inc. ChipInspector allows for single probe chip analysis, including latest up to date genome information from Genomatix“ ElDorado genomic annotation engine.
Applying the full Genomatix chip analysis pipeline to a researcher's microarray results raw data strongly enhances the identification of significantly changed transcripts, generates the full biological network of involved genes, and allows for functional analysis of the sub-networks most relevant for the experimental set-up. Downstream analysis looks for common promoter organization being responsible for co-regulation of involved genes. Large scale genomic database scanning with such organizational patterns identifies additional genes belonging to a common regulatory environment.
Dr. Martin Seifert, Vice President of Microarray Business at Genomatix stated: "I am very happy that the renowned experts from the NIH will be among the first non-Genomatix scientists who will have access to ChipInspector and our entire chip analysis pipeline. I am very keen to see high level scientific results and expect a boost of new publications citing our tools."
Genomatix was founded 1997 as a spin-off from the GSF - National German Research Center for Environment and Health. It developed a multilayer integrative approach aimed at understanding differential gene expression and regulation at the molecular level. Genomatix offers a complete solution from microarray analysis, via pathway knowledge bases and analysis, down to regulatory sequence analysis for transcriptional co-regulation. Genomatix enables better understanding of biological mechanisms under different conditions and stimuli and helps to discover new contexts from biological data. Genomatix has more than 160 peer reviewed scientific publications which are cited in more than 4,000 papers.
Genomatix tools and databases today are applied by more than 25,000 researchers worldwide.
Source: Eurekalert & othersLast reviewed: By John M. Grohol, Psy.D. on 21 Feb 2009
Published on PsychCentral.com. All rights reserved.